Treatment persistence and adherence and their consequences on patient outcomes of generic versus brand-name statins routinely used to treat high cholesterol levels in Spain: a retrospective cost-consequences analysis

BACKGROUND: High blood lipoprotein concentrations are one of the major risk factors for cardiovascular diseases. Drug therapy is the base of treatment; statins in particular. Both brand-name and generic presentations are available for statin therapy of high cholesterol levels. Factors that may influ...

Descripción completa

Detalles Bibliográficos
Autores principales: Sicras-Mainar, A., Sánchez-Álvarez, L., Navarro-Artieda, R., Darbà, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6284297/
https://www.ncbi.nlm.nih.gov/pubmed/30522491
http://dx.doi.org/10.1186/s12944-018-0918-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6284297/
https://www.ncbi.nlm.nih.gov/pubmed/30522491
http://dx.doi.org/10.1186/s12944-018-0918-y

Ejemplares similares